
European Non-invasive Prenatal Testing Market, Forecast to 2028
Description
European Non-invasive Prenatal Testing Market, Forecast to 2028
The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products’ non-invasive nature compared to traditional invasive prenatal testing methods like amniocentesis or chorionic villus sampling (CVS).
In recent years, the European NIPT market has displayed a notable trend toward personalized medicine. Technological innovations have led to the development of advanced NIPT tests that offer higher accuracy in detecting chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). Additionally, the growing preference for early and non-invasive prenatal screening has significantly contributed to the market's expansion.
The intense competition within the NIPT industry in Europe is fueled by advancements in technology—bioinformatics, artificial intelligence, next-generation sequencing (NGS)—and the growing need for precise prenatal diagnostics. Additionally, the competitive environment becomes harsher due to broad market penetration, operational efficacy, and innovation. Rising startups are changing the industry by bringing innovative technology like exclusive platforms and AI-powered analytics to meet certain unmet demands. NIPD Genetics and other notable firms are at the forefront of innovation in the field, pioneering innovative testing.
Table of Contents
- Why is it Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on Europe's NIPT Industry
- Growth Opportunities Fuel the Growth Pipeline Engine™
- Summary
- Scope of the Study
- NIPT European Country Segmentation
- Growth Metrics
- Growth Drivers
- Growth Restraints
- Forecast Assumptions
- Revenue Forecast
- Forecast Analysis
- Revenue Forecast by Country
- Forecast Analysis by Country
- Regulatory Landscape for Europe's NIPT Market
- Europe's NIPT Reimbursement Pathways
- Reimbursement Scenario—European Union 5 (EU5)
- NIPT Test Pricing Analysis by Country—2023
- Competitive Environment
- Key Competitors
- Europe's NIPT Market Competitive Landscape
- Europe's NIPT Market Competitive Landscape by Player
- Competitive Mapping by NIPT Offering Parameters
- Comparison with the US Market
- Europe's NIPT Market—Notable Activities
- Competitors—NIPT Business Reviews and Milestones
- Companies to Watch—BGI Bioscience
- Companies to Watch—Illumina
- Companies to Watch—PerkinElmer
- Companies to Watch—Roche Diagnostics
- Companies to Watch—Eurofins LifeCodexx GmbH
- Companies to Watch—Yourgene Health Plc (Novacyt)
- Companies to Watch—Cradle Genomics
- Companies to Watch—Natera, Inc.
- Companies to Watch—Quest Diagnostics
- Companies to Watch—NIPD Genetics
- Companies to Watch—Progenity (Biora Therapeutics, Inc.)
- Companies to Watch—Everly Health
- Companies to Watch—Labcorp
- Industry Mega Trends
- Growth Opportunity Summary
- Growth Opportunity 1: eCommerce and DTC Sales
- Growth Opportunity 2: Partnerships and Joint Ventures with Local Labs in Europe
- Growth Opportunity 3: Low-Cost Solutions Leading to Cost-efficiency and Accessibility for Market Expansion
- Your Next Steps
- Why Frost, Why Now?
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.